| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/23/2011 | EP2296663A1 Combinations comprising methotrexate and dhodh inhibitors |
| 03/23/2011 | EP2296662A1 Inhibitors of plk |
| 03/23/2011 | EP2296660A1 Anti-tumour compositions and methods |
| 03/23/2011 | EP2296654A1 8-hydroxyquinoline derivatives for the treatment of hematological malignancies |
| 03/23/2011 | EP2296645A2 Combination antitumor therapy |
| 03/23/2011 | EP2203440B1 Inhibitors of the interaction between mdm2 and p53 |
| 03/23/2011 | EP2144909B1 [2,6]naphthyridines useful as protein kinase inhibitors |
| 03/23/2011 | EP2118111B1 2-amin0-5, 7-dihydr0-6h- pyrrolo [3, 4-d] pyrimidine derivatives as hsp-90 inhibitors for treating cancer |
| 03/23/2011 | EP2109608B1 Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
| 03/23/2011 | EP2076260B1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 03/23/2011 | EP1983990B1 A3 adenosine receptor allosteric modulators |
| 03/23/2011 | EP1965801B1 Combination of azd2171 and pemetrexed |
| 03/23/2011 | EP1851228B1 Pyrimidothiophene compounds having hsp90 inhibitory activity |
| 03/23/2011 | EP1545519B1 Combination therapy for hyperproliferative diseases |
| 03/23/2011 | EP1469878B1 Fgfr agonists |
| 03/23/2011 | EP1463529B9 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/23/2011 | EP1432669B1 4-(c2-6 alkoxy)-substituted chalcones as therapeutic agents |
| 03/23/2011 | EP1330444B1 Nitrogenous heterocyclic compounds and process for making them |
| 03/23/2011 | EP1320386B1 A novel cationic lipopolymer as biocompatible gene delivery agent |
| 03/23/2011 | EP1320377B1 Hla binding peptides and their uses |
| 03/23/2011 | EP1285004B1 method of producing synthetic peptides |
| 03/23/2011 | EP1087960B1 Macrocyclic analogs and methods of their use and preparation |
| 03/23/2011 | CN1990489B Use of bohnenkraut ethers compounds and compositions thereof |
| 03/23/2011 | CN1990032B Composite intravenous injection emulsion of glossy ganoderma spore oil and coix seed oil and method for making same |
| 03/23/2011 | CN1929824B Soft gelatin capsule comprising omega-3-polyunsaturated fatty acid |
| 03/23/2011 | CN101990548A Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions |
| 03/23/2011 | CN101990538A C-met protein kinase inhibitors |
| 03/23/2011 | CN101990442A Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties |
| 03/23/2011 | CN101990441A Biocompatible biodegradable fumagillin analog conjugates |
| 03/23/2011 | CN101990438A Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 03/23/2011 | CN101990435A Selective agonist of toll-like receptor 3 |
| 03/23/2011 | CN101988057A Promoter and application thereof |
| 03/23/2011 | CN101988051A Baculovirus expressed antitumor Onconase protein |
| 03/23/2011 | CN101987873A P53 fusion protein and application thereof |
| 03/23/2011 | CN101987865A Antagonist of luteinizing hormone releasing hormone (LHRH) containing hydantoin structure |
| 03/23/2011 | CN101987857A Method for synthesizing capecitabine serving as an antineoplastic medicament and intermediate thereof |
| 03/23/2011 | CN101987848A New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them |
| 03/23/2011 | CN101987847A Novel heterocyclic NF-kB inhibitors |
| 03/23/2011 | CN101987835A Homopiperazine acethydrazide derivatives |
| 03/23/2011 | CN101987203A Method for preparing magnetic gene-loaded lipid ultrasonic microbubble contrast medium |
| 03/23/2011 | CN101987197A Method and reagent for inhibiting invasiveness of cancer cells |
| 03/23/2011 | CN101987111A Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 03/23/2011 | CN101987086A Ultra-fine bicalutamide oral tablet and preparation method thereof |
| 03/23/2011 | CN101843621B TS-1 granules and preparation method thereof |
| 03/23/2011 | CN101757562B Traditional Chinese medicine composition for treating mid-term malignant liver tumor symptoms and preparation method thereof |
| 03/23/2011 | CN101711765B Dispersing tablet containing tegafur, gimeracil and oteracil potassium |
| 03/23/2011 | CN101565443B New fir triterpene lactone compound, preparation method and application thereof |
| 03/23/2011 | CN101564469B Lycium barbarum polysaccharide extract and pharmaceutical application thereof |
| 03/23/2011 | CN101485823B Medicament for treating lung cancer and preparation method thereof |
| 03/23/2011 | CN101481379B Compound separated from acetic acid ethyl ester extract of ginko endogenetic fungal bacterial strain fermentation liquor |
| 03/23/2011 | CN101406625B Chinese medicinal composition for treating cancer as well as preparation method and use thereof |
| 03/23/2011 | CN101385843B Nano medicine magnet therapy plaster for relieving the swelling and easing pain |
| 03/23/2011 | CN101313901B Medicine uses of herpetone |
| 03/23/2011 | CN101292957B Liposome preparation of teniposide phospholipid complexes and preparing method thereof |
| 03/23/2011 | CN101283998B Application of bromine phenolic compound in preparing the medicine for curing the malignancy |
| 03/23/2011 | CN101175753B Compounds and compositions as protein kinase inhibitors |
| 03/23/2011 | CN101168008B Medicinal composition with tumor inhibition function and preparation method and application thereof |
| 03/23/2011 | CN101070350B Intensified fusion protein NGR-LDP-AE formed by target peptide to CD13 and lidamycin |
| 03/23/2011 | CN101053437B Organic germanium Ge-132 glossy ganoderma beverage and processing method |
| 03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 03/22/2011 | US7910693 Prostate cancer diagnosis and treatment |
| 03/22/2011 | US7910594 Antiproliferative agents; gene overexpression |
| 03/22/2011 | US7910593 Water-soluble prodrugs |
| 03/22/2011 | US7910567 Opticin nucleic acid administration reduces blood vessel formation |
| 03/22/2011 | US7910564 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 03/22/2011 | US7910551 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/22/2011 | US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression |
| 03/22/2011 | US7910368 Method of extended culture for antigen-specific cytotoxic lymphocytes |
| 03/22/2011 | US7910314 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer |
| 03/22/2011 | US7910103 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 03/22/2011 | US7910097 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof |
| 03/22/2011 | CA2632091C Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1h-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production |
| 03/22/2011 | CA2492342C Novel bio-active pyrimidine derivatives |
| 03/22/2011 | CA2488001C 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
| 03/22/2011 | CA2480880C Inhibitors of akt activity |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/22/2011 | CA2471543C Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2460036C Medical devices containing rapamycin analogs |
| 03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
| 03/22/2011 | CA2445333C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 03/22/2011 | CA2433675C Pharmaceutically active piperidine derivatives |
| 03/22/2011 | CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 03/22/2011 | CA2407592C Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 03/22/2011 | CA2396186C Agents for the treatment of skin disorders |
| 03/22/2011 | CA2390166C Hedgehog fusion proteins and uses |
| 03/22/2011 | CA2371765C Isoflavone metabolites |
| 03/22/2011 | CA2359334C Bifidobacterium in the treatment of inflammatory disease |
| 03/22/2011 | CA2335941C Treatment of hyperproliferative disorders |
| 03/22/2011 | CA2308127C Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 03/17/2011 | WO2011032169A2 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same |
| 03/17/2011 | WO2011032161A2 Vaccines directed to langerhans cells |
| 03/17/2011 | WO2011032003A1 Immunization to reduce neurotoxicity during treatment with cytolytic viruses |
| 03/17/2011 | WO2011032000A2 Method for protection of antimicrobial and anticancer drugs from inactivation by nitric oxide |
| 03/17/2011 | WO2011031974A1 Acridine analogs in the treatment of gliomas |
| 03/17/2011 | WO2011031955A2 Optical monitoring of leukemia |
| 03/17/2011 | WO2011031919A2 Non-radioactive phospholipid compounds, compositions, and methods of use |
| 03/17/2011 | WO2011031890A2 Cancer stem cell-targeted and drug resistant cancer therapy |
| 03/17/2011 | WO2011031884A2 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides |